Single Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy Subjects
Clinical trial NCT04136145 · COMPLETED
Trial details
- NCT number
- NCT04136145
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-28
- Primary completion
- 2020-01-14
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.